Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: A New Cause of Hypertension

E-ISSN： 1875-6506|3|2|149-155

ISSN： 1573-4021

Source： Current Hypertension Reviews, Vol.3, Iss.2, 2007-05, pp. : 149-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs

Current Vascular Pharmacology, Vol. 9, Iss. 3, 2011-05 ,pp. : 358-380

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular endothelial growth factor (VEGF) in endometriosis

By Donnez J Smoes P Gillerot S Casanas-Roux F Nisolle M

Human Reproduction, Vol. 13, Iss. 6, 1998-06 ,pp. : 1686-1690

Oxford University Press

Access to resources Recommend Favorite

Anti-Vascular Endothelial Growth Factor Drug Treatment of Diabetic Macular Edema: The Evolution Continues

Current Diabetes Reviews, Vol. 8, Iss. 4, 2012-07 ,pp. : 237-246

Bentham Science Publishers

Access to resources Recommend Favorite

Combination of Vascular Endothelial Growth Factor (VEGF) and Thymidine Phosphorylase (TP) to Improve Angiogenic Gene Therapy

By Bouïs Diane Boelens Mirjam Peters Erna Koolwijk Pieter Stob Gerrie Kema Ido Klinkenberg Marco Mulder Nanno Hospers Geke

Angiogenesis, Vol. 6, Iss. 3, 2003-01 ,pp. : 185-192

Springer Publishing Company

Access to resources Recommend Favorite

Anti‐epidermal or anti‐vascular endothelial growth factor as first‐line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients

Journal Of Cachexia Sarcopenia And Muscle, Vol. 6, Iss. 3, 2015-09 ,pp. : 231-236

John Wiley & Sons Inc

Access to resources Recommend Favorite